Tumor Resistance Explained by Hormesis
Enhanced drug (GDC 0449) resistance in a mouse model for human medulloblastoma is shown in the present paper to act via an hormetic response. This has significant implications, imposing constraints on the quantitative features of the dose response of the chemotherapeutic agent, affecting optimal stu...
Main Authors: | Edward J. Calabrese Ph.D., Marc A. Nascarella Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-01-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.2203/dose-response.09-063.Calabrese |
Similar Items
-
Exposure to Nanoparticles and Hormesis
by: Ivo Iavicoli, et al.
Published: (2010-10-01) -
Hormesis and the Salk Polio Vaccine
by: Edward J. Calabrese Ph.D.
Published: (2012-01-01) -
A Method to Evaluate Hormesis in Nanoparticle Dose-Responses
by: Marc A. Nascarella, et al.
Published: (2012-07-01) -
Quantification of Hormesis in Anticancer-Agent Dose-Responses
by: Marc A. Nascarella, et al.
Published: (2009-04-01) -
Radiation-Induced Neoplastic Transformation , Hormesis and Risk Assessment
by: J. Leslie Redpath PhD, et al.
Published: (2007-04-01)